 SAN DIEGO , Dec. 22, 2022 PRNewswire -- Mirati Therapeutics, Inc. NASDAQ: MRTX, a commercial-stage targeted oncology company, today announced that the Company will present at the 41st J.P. Morgan Annual Healthcare Conference, on January 9, 2023. 